Entry Detail



General Information

Database ID:exR0354308
RNA Name:hsa-miR-302c-3p
RNA Type:miRNA
Chromosome:chr4
Starnd:-
Coordinate:
Start Site(bp):112648366End Site(bp):112648388
External Links:hsa-miR-302c-3p



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE93850
Description:Serum miRNAs in Patients with Glioblastoma Multiforme
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:22
Number of Control:8
Number of Samples:30





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
MTMR12
chr5
32226994
32312987
-
TXNIP
chr1
145992435
145996579
-
CLU
chr8
27596917
27614700
-
MBP
chr18
76978827
77133683
-
CCNB1
chr5
69167135
69178245
+
SETD7
chr4
139495941
139606699
-
NUP153
chr6
17615035
17706834
-
SEC16A
chr9
136440096
136483759
-
SLAIN2
chr4
48341529
48426201
+
ZSCAN26
chr6
28267010
28278224
+
CUL1
chr7
148697914
148801110
+
TRA2A
chr7
23504780
23532041
-
TEFM
chr17
30897336
30906238
-
CCNG2
chr4
77157207
77433388
+
CDK6
chr7
92604921
92836594
-
FYCO1
chr3
45917899
45995824
-
PSMD5
chr9
120815496
120842951
-
MTFR2
chr6
136231024
136250335
-
VRK1
chr14
96797382
96931722
+
UGP2
chr2
63840940
63891562
+
KMT5B
chr11
68154863
68213828
-
SEMA3C
chr7
80742538
80922359
-
COX7C
chr5
86617928
86620962
+
SRRT
chr7
100875103
100888664
+
BCL7A
chr12
122019422
122062044
+
PDXK
chr21
43719094
43762307
+
MOB1A
chr2
74152528
74178898
-
MSTO1
chr1
155610188
155614971
+
NPC2
chr14
74476192
74494177
-
CAMK2N1
chr1
20482391
20486210
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC011503.2
chr19
23927788
23929287
+
AC125257.1
chr17
41848518
41851447
-
AL049840.4
chr14
103694516
103695050
-
ARHGAP27P1-BPTFP1-KPNA2P3
chr17
64749663
64781707
-
FGD5-AS1
chr3
14920347
14948424
-
MIR17HG
chr13
91347820
91354579
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
SNHG16
chr17
76557764
76565348
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE93850
Sample Source:Blood
Source Fraction:Serum
Platform:GPL22948
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:1032
Sample treatment protocol:NA
RNA Extract protocol:Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada)
RNA library preparation protocol:0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.



Reference

PMID:28931080
Title:Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
Author:Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX
Journal:PLoS One. 2017 Sep 20;12(9):e0184969.
Description:we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.